Á. Pascual, S. Ballesta, I. García, E.J. Perea 

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
L. Boyanova  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
Approach to diagnosis of infective endocarditis
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era  T.I. Pedersen, M. Howitz, C. Østergaard  Clinical.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Virological tools to diagnose and monitor hepatitis C virus infection
Link between intracellular pathogens and cardiovascular diseases
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Isospora belli infection in a patient with non-Hodgkin's lymphoma
Structure of grepafloxacin relative to activity and safety profile
Vector control: a cornerstone in the malaria elimination campaign
L. Gatta, C. Ricci, A. Tampieri, D. Vaira 
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Training for the infectious diseases speciality in Norway
Laboratory diagnosis and biosafety issues of biological warfare agents
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Metagenomics and probiotics
Advisory group on Home-based and Outpatient Care (AdHOC): an international consensus statement on non-inpatient parenteral therapy  D. Nathwani, J.-J.
Effect of antioxidants on the immune response of Helicobacter pylori
L. Arreaza, J.A. Vázquez  Clinical Microbiology and Infection 
Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin  King A. , Bathgate.
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease  Inge O. Baas, G. Johan A. Offerhaus, Ralph.
G.R. Davies  Clinical Microbiology and Infection 
A. Bryskier  Clinical Microbiology and Infection 
Pathogenesis of catheter-related infections: lessons for new designs
Antibacterial drug discovery in the 21st century
Community-acquired pneumonia: epidemiologic and clinical consideration
Abstracts cont. Clinical Microbiology and Infection
Abstracts cont. Clinical Microbiology and Infection
Training in infectious diseases and tropical medicine in Britain
Fibronectin concentrations in catheter sepsis
Antimicrobial drug development – the past, the present, and the future
Clinical infection services—the Leiden experience
Comparative pharmacokinetics of macrolide antibiotics and concentrations achieved in polymorphonuclear leukocytes and saliva  Manuel Fassbender, Hartmut.
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Overview of cefixime use in community-acquired infections
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
Carratalà J.   Clinical Microbiology and Infection 
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
N. Markeas, G. Stamos, I. Paraskakis, A. Giokas, G. Pistevos 
J.L. Balcázar  Clinical Microbiology and Infection 
Typing of Clostridium difficile
N. Markeas, G. Stamos, I. Paraskakis, A. Giokas, G. Pistevos 
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
Abstracts Clinical Microbiology and Infection
Localized Mycobacterium avium complex infection in a patient on HAART
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Vincent Calvez, Marc Grandadam  Clinical Microbiology and Infection 
Presentation transcript:

Uptake and intracellular activity of ketolide HMR 3647 in human phagocytic and non- phagocytic cells  Á. Pascual, S. Ballesta, I. García, E.J. Perea  Clinical Microbiology and Infection  Volume 7, Issue 2, Pages 65-69 (February 2001) DOI: 10.1046/j.1469-0691.2001.00213.x Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Uptake and efflux (dotted line) of HMR 3647 in human PMNs and PMOs after removal of the extracellular drug (n = 4). Extracellular ketolide concentration: 2 mg/L. Clinical Microbiology and Infection 2001 7, 65-69DOI: (10.1046/j.1469-0691.2001.00213.x) Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Uptake and efflux (dotted line) of HMR 3647 in McCoy and Hep-2 after removal of the extracellular drug (n = 4). Extracellular ketolide concentration: 2 mg/L Clinical Microbiology and Infection 2001 7, 65-69DOI: (10.1046/j.1469-0691.2001.00213.x) Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions